Skip to content
MedCompare

Paliperidone Palmitate

Mental Health
Save $68,764/mo
39× cheaper

INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia in adults [see Clinical Studies (14.1) ]. Schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants [see Clinical Studies (14.2) ].

United States
$70,580
per month
India
$1,816
per month
You save
$68,764
97% cheaper in India
694.6K US scripts/yr$47.8B potential annual savings$49B US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC39H57FN4O4

SMILES: CCCCCCCCCCCCCCCC(=O)OC1CCCN2C1=NC(=C(C2=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F)C

Compare the price
US price$70,580per month
India price$1,816per month
You save$68,76497% less

Based on 30 units per month. US $2,352.66 vs India $60.55 per unit.

Total over 1 periodSave $68,764$70,580 → $1,816
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$412,581
Estimated travel cost
− $2,300
Net savings after travel
$410,281

Even after travel, you could come out ahead by about $410,281.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Paliperidone Palmitate is filled about 694.6K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$49B
If sourced from India
$1.3B
Potential annual savings
$47.8B
−97%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.